4//SEC Filing
TANG CAPITAL PARTNERS LP 4
Accession 0001209191-18-050601
CIK 0000818033other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 12:28 PM ET
Size
10.5 KB
Accession
0001209191-18-050601
Insider Transaction Report
Form 4
TANG KEVIN C
Director10% Owner
Transactions
- Sale
Common Stock
2018-09-12$35.75/sh−2,695,000$96,346,250→ 5,830,215 total(indirect: By LP)
Holdings
- 14,347(indirect: By Trust)
Common Stock
- 6,941
Common Stock
Footnotes (4)
- [F1]The Reporting Person's sale of common stock reported herein may be deemed to be matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 192,308 shares of common stock purchased by the Reporting Person on March 29, 2018. The Reporting Person has sent to the Issuer the full amount of the disgorgeable profit arising from the sale reported herein.
- [F2]The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP.
- [F3]The securities are held by Kevin C. Tang as custodian for his minor children, as Trustee of the Kevin C. Tang Family Trust, and as Trustee of the Tang Advisors, LLC Profit Sharing Plan.
- [F4]2,147 of these securities are held by Kevin C. Tang's IRA.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001191935
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 12:28 PM ET
- Size
- 10.5 KB